Abstract
Rational Drug Design has become a well-established discipline in pharmaceutical research. It uses computational chemistry with the aim to discover or study drugs and their related biologically active molecules. The purpose is to reduce the number of targets for a good drug that have to be subjected to expensive and time-consuming synthesis. The advanced methods developed in this field united with the increased potency of the new computer generation are the tools for the scientist to explore the conformational variability and properties of a large number of potentially active molecules and their interaction with each other or with their biological target (i.e. enzyme or receptor). Among these methodologies, Molecular Dynamics (MD) is one of the most useful tools in this process now routinely used to simulate complex dynamic processes that occur in biological systems such as molecular recognition in drug-receptor complexes. This paper reviews the current status of Molecular Dynamics methods, and some of its most recent and interesting applications in the field of Drug Design and Discovery.
Keywords: Molecular dynamics, drug design, docking, drug-receptor complexes
Current Computer-Aided Drug Design
Title: Molecular Dynamics as a Tool in Rational Drug Design: Current Status and Some Major Applications
Volume: 5 Issue: 4
Author(s): Roberta Galeazzi
Affiliation:
Keywords: Molecular dynamics, drug design, docking, drug-receptor complexes
Abstract: Rational Drug Design has become a well-established discipline in pharmaceutical research. It uses computational chemistry with the aim to discover or study drugs and their related biologically active molecules. The purpose is to reduce the number of targets for a good drug that have to be subjected to expensive and time-consuming synthesis. The advanced methods developed in this field united with the increased potency of the new computer generation are the tools for the scientist to explore the conformational variability and properties of a large number of potentially active molecules and their interaction with each other or with their biological target (i.e. enzyme or receptor). Among these methodologies, Molecular Dynamics (MD) is one of the most useful tools in this process now routinely used to simulate complex dynamic processes that occur in biological systems such as molecular recognition in drug-receptor complexes. This paper reviews the current status of Molecular Dynamics methods, and some of its most recent and interesting applications in the field of Drug Design and Discovery.
Export Options
About this article
Cite this article as:
Galeazzi Roberta, Molecular Dynamics as a Tool in Rational Drug Design: Current Status and Some Major Applications, Current Computer-Aided Drug Design 2009; 5 (4) . https://dx.doi.org/10.2174/157340909789577847
DOI https://dx.doi.org/10.2174/157340909789577847 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Development of Therapeutics for High Grade Gliomas Using Orthotopic Rodent Models
Current Medicinal Chemistry Neurotransmitters and Chemokines Regulate Tumor Cell Migration: Potential for a New Pharmacological Approach to Inhibit Invasion and Metastasis Development
Current Pharmaceutical Design Facile Eco-compactable Design for the Synthesis and Characterization of Silver Nanoparticles
Nanoscience & Nanotechnology-Asia Co-formulation of P-glycoprotein Substrate and Inhibitor in Nanocarriers: An Emerging Strategy for Cancer Chemotherapy
Current Cancer Drug Targets Contribution of Poly(Amino Acids) to Advances in Pharmaceutical Biotechnology
Current Pharmaceutical Biotechnology Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast Cancers
Recent Patents on Anti-Cancer Drug Discovery Manganese Superoxide Dismutase (Sod2) and Redox-Control of Signaling Events That Drive Metastasis
Anti-Cancer Agents in Medicinal Chemistry Strategies for Effective Naked-DNA Vaccination Against Infectious Diseases
Recent Patents on Anti-Infective Drug Discovery Preclinical and Clinical Studies on the Use of Stem Cells for Bone Repair: A Systematic Review
Current Stem Cell Research & Therapy The State-of-Art in Angiogenic Properties of Latex from Different Plant Species
Current Angiogenesis (Discontinued) The Insulin-Like Growth Factor (IGF) Signaling Pathway: Strategies for Successful Therapeutic Tasks in Cancer Treatment
Current Cancer Therapy Reviews The Roles of Sox Family Genes in Sarcoma
Current Drug Targets AIDS-Related Kaposis Sarcoma: State of the Art and Therapeutic Strategies
Current HIV Research RETRACTED: Novel and safer self-inactivating vectors for gene therapy of Wiskott-Aldrich Syndrome
Current Gene Therapy How (and Why) to Revive a Dead Enzyme: The Power of Chemical Rescue
Current Chemical Biology Conventional Anticancer Therapeutics and Telomere Maintenance Mechanisms
Current Pharmaceutical Design Antibodies and their Multivalent Constructs for Cancer Therapy
Protein & Peptide Letters PLK1 Inhibition: Prospective Role for the Treatment of Pediatric Tumors
Current Drug Targets Immobilization and Application of Electrospun Nanofiber Scaffold-based Growth Factor in Bone Tissue Engineering
Current Pharmaceutical Design Chemoradiotherapy of Human Tumors: Novel Approaches from Nanomedicine
Current Pharmaceutical Design